» Articles » PMID: 11597916

Direct and Indirect Bacterial Killing Functions of Neutrophil Defensins in Lung Explants

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Studies of the antimicrobial activity of neutrophil defensins have mostly been carried out in microbiological media, and their effects on the host defense in physiological conditions are unclear. We examined 1) the antibacterial activity of defensins in physiological media with and without lung tissue present, 2) the effect of defensins on hydrogen peroxide (H(2)O(2)) production by lung tissue that had been exposed to bacteria, and 3) the effect of diphenyleneiodonium (DPI), an inhibitor of reactive oxygen species formation, on the antibacterial activity of defensins in the presence of lung tissue. Defensins were incubated with Escherichia coli or Pseudomonas aeruginosa in the absence or presence of primary cultured mouse lung explants. Defensins reduced bacterial counts by approximately 65-fold and approximately 25-fold, respectively, at 48 h; bacterial counts were further decreased by approximately 600-fold and approximately 12,000-fold, respectively, in the presence of lung tissue. Defensins induced H(2)O(2) production by lung tissue, and the rate of killing of E. coli by defensins was reduced by approximately 2,500-fold in the presence of 10 microM DPI. We conclude that defensins exert a significant antimicrobial effect under physiological conditions and that this effect is enhanced in the presence of lung tissue by a mechanism that involves the production of reactive oxygen species.

Citing Articles

activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants.

Escobar-Salom M, Barcelo I, Rojo-Molinero E, Jordana-Lluch E, Cabot G, Oliver A Microbiol Spectr. 2024; 12(4):e0035824.

PMID: 38441982 PMC: 10986477. DOI: 10.1128/spectrum.00358-24.


Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.

Escobar-Salom M, Torrens G, Jordana-Lluch E, Oliver A, Juan C Biol Rev Camb Philos Soc. 2022; 97(3):1005-1037.

PMID: 35043558 PMC: 9304279. DOI: 10.1111/brv.12830.


Modulation of Human Neutrophil Peptides on Killing, Epithelial Cell Inflammation and Mesenchymal Stromal Cell Secretome Profiles.

Dai Q, Morita Y, Huang Y, Liaw P, Wu J, Khang J J Inflamm Res. 2020; 12:335-343.

PMID: 31908518 PMC: 6927223. DOI: 10.2147/JIR.S219276.


Dual effects of human neutrophil peptides in a mouse model of pneumonia and ventilator-induced lung injury.

Zheng J, Huang Y, Islam D, Wen X, Wu S, Streutker C Respir Res. 2018; 19(1):190.

PMID: 30268129 PMC: 6162902. DOI: 10.1186/s12931-018-0869-x.


Identification of Polo-like kinases as potential novel drug targets for influenza A virus.

Pohl M, von Recum-Knepper J, Rodriguez-Frandsen A, Lanz C, Yanguez E, Soonthornvacharin S Sci Rep. 2017; 7(1):8629.

PMID: 28819179 PMC: 5561215. DOI: 10.1038/s41598-017-08942-7.